Id |
Subject |
Object |
Predicate |
Lexical cue |
T192 |
0-4 |
Sentence |
denotes |
4.2. |
T193 |
5-38 |
Sentence |
denotes |
Immune Evasion Mechanisms of PEDV |
T194 |
39-158 |
Sentence |
denotes |
Induction of IFN-α/β is the most rapid and effective mechanism for hosts to initiate antiviral innate immune responses. |
T195 |
159-215 |
Sentence |
denotes |
SARS-CoV, MHV and many other CoVs are sensitive to IFNs. |
T196 |
216-372 |
Sentence |
denotes |
A great number of viral dsRNAs intermediates are generated during CoVs infection that contribute to IFN production, but these CoVs remain highly pathogenic. |
T197 |
373-539 |
Sentence |
denotes |
As a matter of fact, CoVs have developed a set of elaborate mechanisms to evade or inhibit the host antiviral innate immune response during virus evolution [134,167]. |
T198 |
540-900 |
Sentence |
denotes |
The evasive strategies utilized by PEDV are classified into four major types: (1) inhibition of RLRs-mediated IFN production pathways, (2) inhibition of the activation of transcription factors responsible for IFN induction, (3) disruption of the signal cascades induced by IFN, and (4) hiding its viral RNA to avoid the exposure of viral RNA to immune sensors. |
T199 |
901-1092 |
Sentence |
denotes |
In the past decade, accumulating evidence demonstrates that PEDV N protein, nsp1, PLP2, nsp5, nsp15, and nsp16 antagonize type I IFN or type III IFNs production [58,65,78,80,100,132,135,168]. |
T200 |
1093-1198 |
Sentence |
denotes |
This explains why only weak IFNs’ and cytokines’ expression is detected in PEDV-infected cells [169,170]. |
T201 |
1200-1206 |
Sentence |
denotes |
4.2.1. |
T202 |
1207-1221 |
Sentence |
denotes |
PEDV N Protein |
T203 |
1222-1395 |
Sentence |
denotes |
N protein, as an abundantly produced structural protein within CoV-infected cells, has multiple functions, including virus replication, transcription, and assembly [56,134]. |
T204 |
1396-1550 |
Sentence |
denotes |
PEDV N protein has been identified as an IFN antagonist that blocks the expression of IFN-β and ISGs by suppression of the IRF3 and NF-κB activities [58]. |
T205 |
1551-1748 |
Sentence |
denotes |
PEDV N protein inhibits the activation of the IFN-β promoter induced by TBK1 and its upstream RIG-I, MDA-5, VISA, and TRAF3, while not affecting the activation of the IFN-β promoter driven by IRF3. |
T206 |
1749-1939 |
Sentence |
denotes |
Further experiments confirm that N directly interacts with TBK1 to obstruct the association between TBK1 and IRF3, which inhibits TBK1-induced IRF3 phosphorylation and IFN-β production [58]. |
T207 |
1940-2036 |
Sentence |
denotes |
Moreover, the effect of PEDV N protein on type III IFN production has also been evaluated [168]. |
T208 |
2037-2279 |
Sentence |
denotes |
N protein inhibits polyinosinic-polycytidylic acid (poly(I:C))-induced IFN-λ3 production by blocking the nuclear translocation of NF-κB, but does not antagonize the type I or type II IFN expression induced by poly(I:C) in IPEC-J2 cells [168]. |
T209 |
2280-2418 |
Sentence |
denotes |
Recent studies show that SARS-CoV N protein inhibits type I IFN production through suppressing TRIM25-mediated RIG-I ubiquitination [171]. |
T210 |
2419-2502 |
Sentence |
denotes |
The MERS-CoV N protein also blocks IFN production by interacting with TRIM25 [171]. |
T211 |
2503-2735 |
Sentence |
denotes |
In addition, both MHV and SARS-CoV N proteins perturb the function of cellular protein activator of protein kinase R (PACT), which can bind to RIG-I and MDA5 to activate IFN production, and thus antagonize type-I IFN signaling [61]. |
T212 |
2736-2846 |
Sentence |
denotes |
These results indicate the important function of the CoVs N protein in modulating host innate immune response. |
T213 |
2847-2916 |
Sentence |
denotes |
Whether PEDV N protein targets TRIM25 or PACT should be investigated. |
T214 |
2917-3127 |
Sentence |
denotes |
Although several studies have been performed to understand the pathogenicity of PEDV, there remains limited information about the interaction between viral proteins and host cell factors during viral infection. |
T215 |
3128-3197 |
Sentence |
denotes |
CoV N protein is a vital viral protein involved in virus replication. |
T216 |
3198-3393 |
Sentence |
denotes |
Current researches have indicated that N protein interacts with many host proteins, such as hCypA [172], proteasome subunit p42 [173], Smad3 [174], hnRNP-A1 [175], and the chemokine CXCL16 [176]. |
T217 |
3394-3470 |
Sentence |
denotes |
In the host cells, a large number of host proteins reveal various functions. |
T218 |
3471-3550 |
Sentence |
denotes |
However, for the virus, the genome only encodes several limited viral proteins. |
T219 |
3551-3663 |
Sentence |
denotes |
Therefore, these viral proteins have to be multifunctional, which is pivotal to virus replication and existence. |
T220 |
3665-3671 |
Sentence |
denotes |
4.2.2. |
T221 |
3672-3681 |
Sentence |
denotes |
PEDV nsp1 |
T222 |
3682-3842 |
Sentence |
denotes |
PEDV nsp1 is the N-terminal cleavage product from polyproteins pp1a and pp1a/b processed by nsp3 and nsp5 [177] and is about 110 amino acids in length [74,178]. |
T223 |
3843-3990 |
Sentence |
denotes |
Nsp1 of many α-CoV and β-CoV exhibits both functional conservation and mechanistic diversity in suppressing host gene expression and IFN signaling. |
T224 |
3991-4150 |
Sentence |
denotes |
For SARS-CoV, nsp1 triggers the decay and cleavage of host mRNA and inhibits host protein translation, subsequently inhibiting type I IFN production [179,180]. |
T225 |
4151-4288 |
Sentence |
denotes |
SARS-CoV nsp1 also blocks the expression of IFN-inducible genes, by restraining the signal transduction during virus infection [181,182]. |
T226 |
4289-4379 |
Sentence |
denotes |
The TGEV nsp1 considerably suppresses host protein expression during viral infection [77]. |
T227 |
4380-4505 |
Sentence |
denotes |
Structural studies show that the core structure of PEDV nsp1 is highly similar to those of SARS-CoV nsp1 and TGEV nsp1 [183]. |
T228 |
4506-4734 |
Sentence |
denotes |
PEDV nsp1 inhibits host gene expression and three motifs (amino acids 67 to 71, 78 to 85, and 103 to 110) form a stable functional region for inhibition of host protein synthesis, differing considerably from SARS-CoV nsp1 [183]. |
T229 |
4735-4852 |
Sentence |
denotes |
PEDV nsp1 has been identified as an IFN antagonist, which constrains poly (I:C)-induced IFN-β promoter activity [65]. |
T230 |
4853-5012 |
Sentence |
denotes |
Nsp1 significantly inhibits the activation of IFN-β promoter triggered by IRF3, whereas it does not inhibit IRF3 phosphorylation and its nuclear translocation. |
T231 |
5013-5167 |
Sentence |
denotes |
Nsp1 interrupts the association of IRF3 with CREB-binding protein (CBP), by promoting CBP degradation in the nucleus via the proteasome-dependent pathway. |
T232 |
5168-5308 |
Sentence |
denotes |
CBP/p300, the transcription co-activator cAMP responsive element binding protein (CREB), forms a complex with the activated IRF3 in nucleus. |
T233 |
5309-5548 |
Sentence |
denotes |
The IRF3-CBP/p300 complex binds to the positive regulatory domain (PRD) regions of the IFN-β promoter, to assemble the enhanceosome with NF-κB and other factors, which ultimately turn on the transcription of type I IFN genes [184,185,186]. |
T234 |
5549-5614 |
Sentence |
denotes |
Therefore, PEDV nsp1 blocks type I IFN production in the nucleus. |
T235 |
5615-5747 |
Sentence |
denotes |
Activated NF-κB induces the production of type I IFNs and proinflammatory cytokines and is important for inhibiting viral infection. |
T236 |
5748-5897 |
Sentence |
denotes |
PEDV nsp1 has been shown to interfere with the NF-κB activity [78] and is the most potent suppressor of proinflammatory cytokines at early infection. |
T237 |
5898-6092 |
Sentence |
denotes |
It inhibits the phosphorylation and degradation of IκBα, and blocks p65 nuclear translocation, leading to the suppression of both IFN and the early production of pro-inflammatory cytokines [78]. |
T238 |
6093-6251 |
Sentence |
denotes |
Moreover, PEDV inhibits type III IFN production and nsp1, nsp3, nsp5, nsp8, nsp14, nsp15, nsp16, ORF3, E, M, and N are identified as type III IFN antagonists. |
T239 |
6252-6318 |
Sentence |
denotes |
Among these antagonists, nsp1 is the most potent suppressor [130]. |
T240 |
6319-6459 |
Sentence |
denotes |
PEDV nsp1 blocks the nuclear translocation of IRF1 and decreases the amounts of peroxisomes and then suppresses IRF1-mediated type III IFNs. |
T241 |
6460-6542 |
Sentence |
denotes |
The conserved residues of PEDV nsp1 protein are crucial for IFN suppression [130]. |
T242 |
6543-6688 |
Sentence |
denotes |
Multiple effects of nsp1 on modulating innate immune response during PEDV infection suggest the vital role of nsp1 in the PEDV replication cycle. |
T243 |
6690-6696 |
Sentence |
denotes |
4.2.3. |
T244 |
6697-6701 |
Sentence |
denotes |
PLP2 |
T245 |
6702-7060 |
Sentence |
denotes |
The antiviral innate immune signaling pathways are regulated by several posttranslational modifications (PTMs), such as phosphorylation, ubiquitination, glycosylation, NEDDylation and SUMOylation [187], of which ubiquitination is a critical modification to modulate the stability and activity of PRRs and other components of innate immune signaling pathways. |
T246 |
7061-7216 |
Sentence |
denotes |
During viral infection, a reciprocatory action (occurrence of ubiquitination and deubiquitination) helps maintain the homeostasis of host immune responses. |
T247 |
7217-7327 |
Sentence |
denotes |
Hence, deubiquitinases (DUBs) are indispensable in the regulation of virus-induced type I IFN signaling [188]. |
T248 |
7328-7439 |
Sentence |
denotes |
Many host DUBs have been reported engaging in the regulation of innate immune signaling pathways [189,190,191]. |
T249 |
7440-7585 |
Sentence |
denotes |
In recent years, a variety of viral DUBs have been discovered to target key components of type I IFN pathway during various RNA virus infections. |
T250 |
7586-7829 |
Sentence |
denotes |
For example, foot-and-mouth disease virus leader proteinase (FMDV Lbpro) [192], and porcine reproductive and respiratory syndrome virus nsp2 (PRRSV nsp2) possess ubiquitin-deconjugating activity to deubiquitinate key host components [193,194]. |
T251 |
7830-7942 |
Sentence |
denotes |
To counteract host antiviral response, CoVs likely take advantage of DUB activity to break host innate immunity. |
T252 |
7943-8090 |
Sentence |
denotes |
Indeed, the PLPs of mouse hepatitis virus A59 (MHV-A59) [195], SARS [196], and human CoV NL63 have DUB activity and antagonize IFN induction [197]. |
T253 |
8091-8219 |
Sentence |
denotes |
PEDV PLP2 has been reported as having a deubiquitinase activity as well, and it can be co-immunoprecipitated by RIG-I and STING. |
T254 |
8220-8389 |
Sentence |
denotes |
As mentioned above, FMDV Lbpro, MHV PLP2 and SARS PLPs all counteract host innate immune response through blocking the ubiquitination of the components of RLRs pathways. |
T255 |
8390-8535 |
Sentence |
denotes |
Similarly, PEDV PLP2 removes the ubiquitinated conjugates from RIG-I and STING by its DUB activity, to negatively regulate type I IFN production. |
T256 |
8536-8699 |
Sentence |
denotes |
PEDV PLP2 probably interacts with RIG-I and STING, which prevents the activation of RIG-I and STING by hindering the recruitment of downstream signaling molecules. |
T257 |
8700-8820 |
Sentence |
denotes |
As expected, the interference with the ubiquitination of RIG-I and STING by PLP2 clearly benefits PEDV replication [80]. |
T258 |
8821-8881 |
Sentence |
denotes |
PEDV nsp3 contains two core domains of PLPs (PLPl and PLP2). |
T259 |
8882-8985 |
Sentence |
denotes |
It is determined that PEDV PLP2, but not PLP1, inhibits the IFN-β promoter activation in HEK293T cells. |
T260 |
8986-9057 |
Sentence |
denotes |
The DUB activity of PLP2 is highly dependent on its catalytic activity. |
T261 |
9058-9239 |
Sentence |
denotes |
Three catalytically inactive mutants of PEDV PLP2 (C1729A, H1888A and D1901A) are defective in the deubiquitination of its targets and fail to impair virus-induced IFN-β production. |
T262 |
9240-9420 |
Sentence |
denotes |
SARS-CoV PLP2 interacts with MDM2 (mouse double minute 2 homolog) to deubiquitinate and stabilize MDM2, approving the degradation of p53 and the suppression of IFN signaling [198]. |
T263 |
9421-9490 |
Sentence |
denotes |
PEDV infection degrades p53 by upregulation of MDM2 expression [198]. |
T264 |
9491-9616 |
Sentence |
denotes |
PEDV PLP2 may be responsible for targeting the p53 pathway and inhibiting p53-dependent apoptosis, leading to immune evasion. |
T265 |
9617-9790 |
Sentence |
denotes |
A recent study determined that TGEV PL1 inhibits the IFN-β expression and interferes with the RIG-1- and STING-mediated signaling pathway through a viral DUB activity [195]. |
T266 |
9791-9906 |
Sentence |
denotes |
It suggests that different viral proteins are involved in the deubiquitination of host proteins for different CoVs. |
T267 |
9907-10061 |
Sentence |
denotes |
However, these studies offer a probability to design a common therapeutic against different viral DUBs to reduce the replication and pathogenesis of CoVs. |
T268 |
10062-10236 |
Sentence |
denotes |
Therefore, further studies are required to understand more about the substrate specificity of these viral DUBs and clarify the precise functions of CoV protease/DUB activity. |
T269 |
10238-10244 |
Sentence |
denotes |
4.2.4. |
T270 |
10245-10254 |
Sentence |
denotes |
PEDV nsp5 |
T271 |
10255-10362 |
Sentence |
denotes |
Notably, 3Cpro is a critical IFN antagonistic protein identified in multiple different families of viruses. |
T272 |
10363-10644 |
Sentence |
denotes |
The 3Cpro of picornaviruses, including FMDV [199], hepatitis A virus (HAV) [200], enteroviruses (EV71, EV-D68) and coxsackieviruses (CVB3, CV-A16, CV-A6) [201,202,203,204], antagonize innate immune signaling by targeting the critical components of the IFN pathways for proteolysis. |
T273 |
10645-10797 |
Sentence |
denotes |
A newly emerged picornavirus, Seneca Valley virus (SVV), has also evolved an effective mechanism to escape host antiviral innate immune using its 3Cpro. |
T274 |
10798-11010 |
Sentence |
denotes |
Moreover, 3Cpro cleaves the signaling components (MAVS, TRIF, and TANK) of type I IFN pathway and induces the degradation of the transcription factors IRF3 and IRF7 to constrain host antiviral response [205,206]. |
T275 |
11011-11103 |
Sentence |
denotes |
CoV nsp5 is called 3C-like protease (3CLpro), that resembles the 3Cpro of other RNA viruses. |
T276 |
11104-11229 |
Sentence |
denotes |
For CoV, the polyprotein precursors (pp1a and pp1b) are mainly processed to generate mature nonstructural proteins by 3CLpro. |
T277 |
11230-11417 |
Sentence |
denotes |
To date, the 3CLpro of CoVs, including PEDV and PDCoV, have been confirmed to antagonize type I IFN production by the cleavage of NF-κB essential modulator (NEMO) and STAT2 [100,207,208]. |
T278 |
11418-11500 |
Sentence |
denotes |
NEMO is essential for RNA virus-induced activation of NF-κB, IRF3, and IRF7 [209]. |
T279 |
11501-11611 |
Sentence |
denotes |
NEMO is required for MAVS-induced IKKα/β activation and is also crucial for the activation of TBK1/IKKε [149]. |
T280 |
11612-11706 |
Sentence |
denotes |
To establish successful infections, PEDV targets NEMO to subvert host innate immune responses. |
T281 |
11707-11838 |
Sentence |
denotes |
PEDV nsp5 significantly inhibits Sendai virus (SeV)-induced IFN-β synthesis and the process depends on its protease activity [100]. |
T282 |
11839-11942 |
Sentence |
denotes |
Further experiments show that PEDV nsp5 inhibits RIG-I/MDA5 signaling and targets the upstream of TBK1. |
T283 |
11943-12028 |
Sentence |
denotes |
The cleavage of NEMO by nsp5 is identified as responsible for this inhibitive effect. |
T284 |
12029-12123 |
Sentence |
denotes |
The PEDV nsp5-mediated cleavage of NEMO efficiently blocks NEMO-mediated downstream signaling. |
T285 |
12124-12198 |
Sentence |
denotes |
The cleavage site within NEMO that is grasped by nsp5 has been determined. |
T286 |
12199-12366 |
Sentence |
denotes |
Of these reported immune evasion strategies employed by CoVs, the cleavage of innate immune adaptors is a particularly effective manner to disrupt antiviral responses. |
T287 |
12367-12437 |
Sentence |
denotes |
Nsp5 is essential for the life cycle of PEDV and other CoVs [210,211]. |
T288 |
12438-12516 |
Sentence |
denotes |
It is a potential target for the development of anti-coronaviral therapeutics. |
T289 |
12517-12689 |
Sentence |
denotes |
Although PEDV nsp5 does not target STAT2 mediated type Ⅰ IFN signaling pathway, PEDV nsp7 has been reported to inhibit the STAT1 and STAT2 induced activation of ISRE [212]. |
T290 |
12690-12854 |
Sentence |
denotes |
Nsp7 competes with Karyopherin α (KPNA1), which is an adaptor mediating nuclear translocation of ISGF3, in combination with STAT1, to block ISGF3 nuclear transport. |
T291 |
12855-12948 |
Sentence |
denotes |
However, the expression and phosphorylation of STAT1 and STAT2 are not affected by PEDV nsp7. |
T292 |
12949-13038 |
Sentence |
denotes |
In fact, PEDV infection degrades STAT1, leading to the inhibition of IFN signaling [170]. |
T293 |
13039-13116 |
Sentence |
denotes |
Therefore, other PEDV encoded proteins likely target IFNs mediated signaling. |
T294 |
13118-13124 |
Sentence |
denotes |
4.2.5. |
T295 |
13125-13157 |
Sentence |
denotes |
Evasion of Viral RNA Recognition |
T296 |
13158-13299 |
Sentence |
denotes |
CoVs belong to RNA viruses, which produce several RNA species, such as dsRNA intermediates and RNA with a 5′-triphosphate during replication. |
T297 |
13300-13435 |
Sentence |
denotes |
These RNA intermediates are potent stimulators of PRRs and are associated with the organelles of viral RNA replication, DMVs [213,214]. |
T298 |
13436-13597 |
Sentence |
denotes |
DMVs formed from membranous rearrangements seem to sequester the replication intermediates using membrane-bound vesicles or invaginations to keep away from PRRs. |
T299 |
13598-13715 |
Sentence |
denotes |
Therefore, the form of DMVs may be a strategy for PEDV to escape innate immune recognition in the cytosol (Figure 2). |
T300 |
13716-13799 |
Sentence |
denotes |
However, whether DMVs alone are sufficient to shield RNA from PRRs remains unknown. |
T301 |
13800-14017 |
Sentence |
denotes |
Besides, the replication organelles, the endoribonuclease activity and viral 5′ end RNA capping/protection mechanisms are also the critical ways of avoiding RNA recognition or protecting it from degradation [132,135]. |
T302 |
14018-14031 |
Sentence |
denotes |
1) PEDV nsp15 |
T303 |
14032-14140 |
Sentence |
denotes |
CoV nsp15 has EndoU catalytic activity that was initially thought to play a vital role in virus replication. |
T304 |
14141-14277 |
Sentence |
denotes |
However, the catalytic-defective EndoU of MHV shows only a subtle defect in viral replication compared to WT virus in fibroblasts [215]. |
T305 |
14278-14358 |
Sentence |
denotes |
Similar results are found for the nsp15 mutants of SARS-CoV and HCoV-229E [216]. |
T306 |
14359-14449 |
Sentence |
denotes |
These findings suggest that the EndoU activity of nsp15 is not required for RNA synthesis. |
T307 |
14450-14541 |
Sentence |
denotes |
Recently, nsp15 has been demonstrated to act as a new IFN antagonist of CoVs [117,118,217]. |
T308 |
14542-14701 |
Sentence |
denotes |
Recent reports indicate that CoVs’ EndoU activity is essential for prevention of RNA recognition by MDA5, protein kinase R (PKR), and OAS/RNAse L system [118]. |
T309 |
14702-14798 |
Sentence |
denotes |
PKR and OAS/RNAse L recognize and destroy foreign RNA in the cytosol to defend viral infections. |
T310 |
14799-14947 |
Sentence |
denotes |
To counteract the function of PKR and OAS/RNAse L, the virus hides or modifies its viral RNA, to avoid the exposure of viral RNA to these molecules. |
T311 |
14948-15017 |
Sentence |
denotes |
In all CoVs, the EndoU catalytic domain in nsp15 is highly conserved. |
T312 |
15018-15113 |
Sentence |
denotes |
PEDV EndoU activity has been indicated as having an antagonistic effect on IFN signaling [135]. |
T313 |
15114-15288 |
Sentence |
denotes |
The EndoU activity of PEDV nsp15 not only inhibits the type I IFN response in porcine macrophages, but also antagonizes the type III IFN response in porcine epithelial cells. |
T314 |
15289-15437 |
Sentence |
denotes |
The replication of EndoU-mutant PEDV (icPEDV-EnUmt) is considerably impaired in porcine epithelial cells compared to the wild type PEDV (icPEDV-wt). |
T315 |
15438-15593 |
Sentence |
denotes |
The icPEDV-EnUmt clearly induces early and robust type I and type III IFNs production, as well as ISGs’ expression compared with that induced by icPEDV-wt. |
T316 |
15594-15683 |
Sentence |
denotes |
The EndoU-deficient PEDV infected animals also show reduced viral shedding and mortality. |
T317 |
15684-15823 |
Sentence |
denotes |
These results indicate that the EndoU activity of PEDV nsp15 plays a vital role in evading host antiviral innate immunity (Figure 2) [135]. |
T318 |
15824-15837 |
Sentence |
denotes |
2) PEDV nsp16 |
T319 |
15838-15889 |
Sentence |
denotes |
CoV nsp16 is a 2′-O-methyltransferase (2′-O-MTase). |
T320 |
15890-16012 |
Sentence |
denotes |
To evade recognition by the host immune sensors, many CoVs encode methyltransferases involved in the capping of viral RNA. |
T321 |
16013-16176 |
Sentence |
denotes |
This modification makes the viral RNA indistinguishable with host cell mRNA, which is important to avoid the recognition of viral RNA by MDA5 (Figure 2) [121,218]. |
T322 |
16177-16337 |
Sentence |
denotes |
Methylation of the two sites in the 5′ cap is catalyzed by three nsps, including nsp14 (the N-7-MTase), nsp16 (the 2′-O-MTase), and nsp10 [112,123,124,125,126]. |
T323 |
16338-16470 |
Sentence |
denotes |
For example, SARS-CoV nsp16 acts as a 2′-O-MTase to prevent innate immune recognition and promote viral proliferation [113,121,123]. |
T324 |
16471-16551 |
Sentence |
denotes |
PEDV nsp14 and nsp16 have been identified as the viral IFN antagonists [65,132]. |
T325 |
16552-16722 |
Sentence |
denotes |
The overexpression of nsp14 or nsp16 remarkably inhibits IFN-β production, but nsp16 appears to play a more important role in innate immunity regulation than nsp14 [132]. |
T326 |
16723-16848 |
Sentence |
denotes |
Nsp16 is a highly conserved methyltransferase which contains an invariant KDKE motif within the methyltransferase core [219]. |
T327 |
16849-16901 |
Sentence |
denotes |
This KDKE motif is required to mediate its activity. |
T328 |
16902-17010 |
Sentence |
denotes |
Notably, the mutation of any of the KDKE active sit has been shown to abolish the 2′-O-MTase activity [123]. |
T329 |
17011-17179 |
Sentence |
denotes |
PEDV nsp16 KDKE motif plays a critical role in the inhibition of type I IFN production, suggesting the important role of the 2′-O-MTase in PEDV-mediated immune evasion. |
T330 |
17180-17385 |
Sentence |
denotes |
PEDV nsp16 negatively regulates RLR-mediated signal pathway activation, and inhibits the expression of the IFN-stimulated IFIT family members (IFIT1, IFIT2, IFIT3), which in turn promotes PEDV replication. |
T331 |
17386-17528 |
Sentence |
denotes |
Taken together, these results demonstrate that PEDV nsp16 negatively regulates cellular antiviral response to promote viral replication [132]. |
T332 |
17529-17708 |
Sentence |
denotes |
Screening inhibitors targeting the 2′-O-MTase of nsp16 might be a prominent strategy to inhibit CoV infections and develop antivirals for treatment of the diseases caused by CoVs. |
T333 |
17709-17799 |
Sentence |
denotes |
Additionally, CoVs nsp14 also includes the 3′-to-5′ exoribonuclease (ExoN) activity [113]. |
T334 |
17800-17934 |
Sentence |
denotes |
A mutation of TGEV nsp14 ExoN generates lower levels of dsRNA than wildtype TGEV and thus triggers a reduced antiviral response [220]. |
T335 |
17935-18050 |
Sentence |
denotes |
Nsp14 ExoN activity is also critical for the resistance of host innate immune response in MHV-infected cells [221]. |
T336 |
18051-18192 |
Sentence |
denotes |
The role of nsp ExoN activity of PEDV in counteracting host antiviral response should be investigated to uncover more functions of PEDV nsps. |
T337 |
18193-18373 |
Sentence |
denotes |
These data suggest that PEDV has evolved multiple evasive mechanisms to circumvent viral RNA recognition or prevent RNA degradation to establish a successful infection in the host. |
T338 |
18375-18381 |
Sentence |
denotes |
4.2.6. |
T339 |
18382-18462 |
Sentence |
denotes |
PEDV Inhibits Heat Shock Protein 27 Expression to Impair Innate Immune Signaling |
T340 |
18463-18702 |
Sentence |
denotes |
Heat shock protein 27 (HSP27) belongs to the small heat shock proteins family, which has been identified as a multifunctional protein involved in cytoskeletal stability, proinflammatory processes, and the inhibition of apoptosis [222,223]. |
T341 |
18703-18801 |
Sentence |
denotes |
Several HSPs have been reported to be implicated in PEDV infection in vitro and in vivo [224,225]. |
T342 |
18802-18985 |
Sentence |
denotes |
Indeed, the infection of many viruses up-regulates HSP27 expression by different mechanisms to delay cellular apoptosis, then supplies sufficient time for viral replication [226,227]. |
T343 |
18986-19111 |
Sentence |
denotes |
However, PEDV infection significantly induces the decreased expression of HSP27 in Vero cells [225] and MARC-145 cells [228]. |
T344 |
19112-19223 |
Sentence |
denotes |
HSP27 activates the phosphorylation of NF-κB, and thus promotes the mRNA expression of IFN-β in MARC-145 cells. |
T345 |
19224-19357 |
Sentence |
denotes |
As HSP27 is an upstream regulator of antiviral immune signaling, overexpression of HSP27 significantly inhibits the PEDV replication. |
T346 |
19358-19487 |
Sentence |
denotes |
PEDV has developed a strategy via mediating the suppression of HSP27 production to escape from host innate immune response [228]. |
T347 |
19488-19576 |
Sentence |
denotes |
HSP70, the most conserved HSP, is also important for the multiplication of several CoVs. |
T348 |
19577-19686 |
Sentence |
denotes |
The recruitment of HSP70 is thought to be a viral survival strategy for several viruses in their hosts [229]. |
T349 |
19687-19765 |
Sentence |
denotes |
The relationship between HSP70 and PEDV should be exploited further in future. |